Begins Trending PVCT, ORMP, KO, and MCIG

Follow this company

Companies Mentioned

02/04/2014 [ACCESSWIRE]

Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at to get exclusive access to our free stock reports.

Provectus Biopharmaceuticals, Inc. (OTC: PVCT) shares moved up 49.61 percent on over 3.1 million shares traded on Tuesday. The company, a development-stage oncology and dermatology biopharmaceutical company, and XenoTech, a preclinical CRO and pioneer in collaborative research surrounding in vitro drug metabolism and pharmacokinetics (DMPK) services, announced last week that an article describing a study to determine the potential of rose bengal disodium to cause drug-drug interactions has been published by Xenobiotica, a peer-reviewed scientific journal that publishes comprehensive research papers on pharmacokinetics (the study of distribution, metabolism, disposition and excretion of drugs).

Get more information on Provectus Biopharmaceuticals, Inc. and free access to the in-depth equity report at:

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) shares closed down 24.08 percent on Monday with about 3.1 million shares traded. The stock was one of the biggest decliners in the NASDAQ. Pomerantz LLP is investigating claims on behalf of investors of Oramed Pharmaceuticals, Inc. The investigation concerns whether Oramed and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. 

Get more information on Oramed Pharmaceuticals Inc. and free access to the in-depth equity report at:

The Coca-Cola Company (NYSE: KO) shares closed down a modest 1.64 percent on about 23 million shares traded on Monday. Recently criticism erupted on Twitter, Facebook, and other social media outlets about the company’s Super Bowl ad that had "America, the Beautiful" being sung in other languages.

Get more information on The Coca-Cola Company and free access to the in-depth equity report at:

mCig, Inc. (OTCBB: MCIG) shares closed up 18.21 percent on Monday with about 9 million shares traded. The stock was one of the biggest gainers in the OTCBB market and hit a new 52-week high of $0.37 during intra-day trading. The company released its first investor presentation for the month of February 2014. This presentation also known as an "Investor Deck" will serve the company by summarizing the business model and performance metrics to existing investors, potential investors, and potential joint venture partners and brand ambassadors.

Get more information on mCig, Inc. and free access to the in-depth equity report at:


Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures. 


Leave a comment...

Your Name